The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 1, 2001, Pages 50-55

  Kamya, Moses R ^a,c   Dorsey, Grant ^b   Gasasira, Anne ^a   Ndeezi, Grace ^a   Babirye, Juliet N ^a   Staedke, Sarah G ^b   Rosenthal, Philip J ^b  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

Chemotherapy; Chloroquine; Clinical trial; Drug resistance; Malaria; Plasmodium falciparum; Sulfadoxine pyrimethamine; Uganda

Indexed keywords

CHLOROQUINE; FANSIDAR; PARACETAMOL;

AFRICA; AGE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITOLOGY; PATIENT CARE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; TREATMENT FAILURE; UGANDA;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0035726310     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90331-1     Document Type: Article

References (37)

1. Chlorproguanil-dapsone: Effective treatment for uncomplicated falciparum malaria
2. Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria
3. A systematic approach to the development of a rational malaria treatment policy in Zambia
4. Chloroquine-resistant Plasmodium falciparum in Eastern Sudan
5. Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa
6. Chloroquine in Africa: Critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa
7. A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children
8. Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance
9. Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda
10. Chloroquine treatment failure for uncomplicated childhood malaria in an area with drug resistance: Early treatment failure aggravates anaemia
11. Chloroquine versus pyrimethamine/sulphadoxine in the treatment of uncomplicated Plasmodium falciparum malaria in northern Kenya
12. Predictors of treatment failure in multiple drug-resistant falciparum malaria: Results from a 42-day follow-up of 224 patients in eastern Thailand
13. Efficacy of chloroquine on Plasmodium falciparum transmitted in Amani, eastern Usambara Mountains, northeast Tanzania: An area where malaria has recently become endemic
14. Risk factors of chloroquine resistance in Plasmodium falciparum malaria
15. Absence of malaria mortality in villagers with chloroquine-resistant Plasmodium falciparum treated with chloroquine
16. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: Correlation with polymorphisms in the dihyrofolate reductase and dihydropteroate synthetase genes
17. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine, and sulfadoxine-pyrimethamine in western Uganda
18. Adaptation of the Saker-Solomons test: Simple, reliable calorimetric field assays for chloroquine and its metabolites in urine
19. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria
20. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, western Uganda
21. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda
22. Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age
23. Systematic review of amodiaquine treatment in uncomplicated malaria
24. Early clinical failures after pyrimethamine-sulfadoxine treatment of uncomplicated falciparum malaria
25. Chloroquine resistant Plasmodium falciparum in coastal Tanzania: A challenge to the continued strategy of village based chemotherapy for malaria control
26. High level of resistance of Plasmodium falciparum to sulphadoxine-pyrimethamine in children in Tanzania
27. Parasitological and clinical efficacy of 25 mg/kg and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children
28. Malaria: Drug use and the immune response
29. Impact of chloroquine resistance on malaria mortality
30. Artemisinin drugs in the treatment of malaria: From medicinal herb to registered medication
31. Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi
32. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: A double-blind, randomized, controlled trial
33. The changing response of Plasmodium falciparum to antimalarial drugs in East Africa
34. Severe and complicated malaria
35. Antimalarial drug policies: Data requirements, treatment of uncomplicated malaria, and management of malaria in pregnancy
36. Assessment of therapeutic efficacy of antimalarial drugs: For uncomplicated falciparum malaria in areas with intense transmission
37. Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire